Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
Plastic surgeon Johnny Franco, MD, discusses how his firsthand experience with GLP-1s shaped his patient-centered wellness program and what plastic surgeons should know before adding similar treatments to their aesthetic practices.